Pop Therapeutics
PoP Therapeutics is dedicated to developing targeted therapies for diseases such as pancreatic cancer, infectious diseases, COVID-19, and atopic dermatitis. They utilize innovative platform technologies like the EDeN platform, which employs synthetic biology to discover bioactive molecules from extreme environments. Their mission centers on putting patients first to create better drugs with fewer side effects, especially for patients in dire need of new treatment options.
Industries
Nr. of Employees
small (1-50)
Pop Therapeutics
Products
Preclinical programs for pancreatic cancer therapeutics
Preclinical-stage drug discovery programs developing small-molecule candidates for pancreatic cancer derived from environmental natural products using a synthetic-biology-enabled platform.
Preclinical programs for multi-drug resistant infection therapeutics
Preclinical discovery and development of small-molecule candidates aimed at multi-drug resistant bacterial infections, sourced from extreme-environment natural products.
Preclinical programs for antiviral therapeutics (including COVID-19 and emerging viruses)
Preclinical discovery programs focused on antiviral small molecules for COVID-19 and other emerging viral infections using environmental natural-product sources.
Preclinical programs for dermatology therapeutics (atopic dermatitis)
Preclinical-stage discovery of small-molecule candidates for atopic dermatitis derived from natural-product discovery efforts.
Preclinical programs for pancreatic cancer therapeutics
Preclinical-stage drug discovery programs developing small-molecule candidates for pancreatic cancer derived from environmental natural products using a synthetic-biology-enabled platform.
Preclinical programs for multi-drug resistant infection therapeutics
Preclinical discovery and development of small-molecule candidates aimed at multi-drug resistant bacterial infections, sourced from extreme-environment natural products.
Preclinical programs for antiviral therapeutics (including COVID-19 and emerging viruses)
Preclinical discovery programs focused on antiviral small molecules for COVID-19 and other emerging viral infections using environmental natural-product sources.
Preclinical programs for dermatology therapeutics (atopic dermatitis)
Preclinical-stage discovery of small-molecule candidates for atopic dermatitis derived from natural-product discovery efforts.
Services
Collaborative research partnerships leveraging the company's discovery platform to identify novel natural-product-derived leads.
Collaborative research partnerships leveraging the company's discovery platform to identify novel natural-product-derived leads.
Expertise Areas
- Natural product discovery
- Synthetic biology-driven discovery
- Preclinical small-molecule drug development
- Oncology therapeutics (pancreatic cancer focus)
Key Technologies
- Synthetic biology
- Environmental natural-product discovery from extremophiles
- Bioactive molecule discovery platform
- Mechanism-of-action screening and characterization